FNY Investment Advisers’s Marrone Bio Innovations, Inc. MBII Stock Holding History

FNY Investment Advisers’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20,000	Closed	-$23K	–	978
2022 Q2	$23K	Sell	20,000 -25,000	-56%	-$26.1K	0.02%	308
2022 Q1	$48K	Sell	45,000 -80,000	-64%	-$60.4K	0.05%	252
2021 Q4	$90K	Buy	+125,000	New	+$101K	0.05%	217

FNY Investment Advisers's MBII Position: Q3 2022 in Review

FNY Investment Advisers sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 20,000 shares — an estimated $23K sold.

FNY Investment Advisers first reported a position in MBII in Q4 2021 and held it in 3 quarters. The position peaked at $90K in Q4 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

FNY Investment Advisers reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
FNY Investment Advisers sold 20,000 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $23K.
FNY Investment Advisers first reported a position in Marrone Bio Innovations, Inc. in Q4 2021 and held it in 3 quarters.
FNY Investment Advisers's Marrone Bio Innovations, Inc. position peaked at $90K in Q4 2021.
0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on FNY Investment Advisers's 13F filing for Q3 2022, filed 19 Oct 2022.